GNS is a Cambridge, MA based precision medicine company using causal machine learning and simulation to enable a new level of matching drugs, care management programs, medical devices, etc. to individual patients in order to dramatically improve outcomes and avoid $100Bs in the ineffective matching of treatments to patients and the downstream medical cost.